Skip to main content

Day: March 22, 2021

Enlivex Announces Research Collaboration with Yale Cancer Center to Assess Synergistic Effect of Allocetra™ in Combination with Immune Checkpoint Inhibitors

Nes Ziona, Israel, March 22, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company targeting diseased macrophages in patients with sepsis, COVID-19 and solid tumors, together with Yale Cancer Center, a National Cancer Institute-designated comprehensive cancer center, today announced a research collaboration for the assessment of the potential of Allocetra™ to enhance the activity of checkpoint inhibitors in solid tumors.  Allocetra™ is a macrophage-reprogramming immunotherapy product candidate currently in clinical development by Enlivex, as, among other things, a potential therapy in combination with approved immune checkpoint inhibitors for hard-to-treat solid tumors.  Under the strategic collaboration, the parties intend to develop and...

Continue reading

Asia Broadband Goes Live Today With Sales of Gold-Backed Cryptocurrency Token

LAS VEGAS, March 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce the sales launch today of the Company’s AABB Gold (AABBG) cryptocurrency token developed by Core State Holdings, Corp. (CSHC). In order to purchase tokens, AABB Wallet users must update the app or download to install the latest version of the app and pass the Know Your Client (KYC) process. Within this new version of the AABB Wallet, the token will only be available for purchase in exchange for other major cryptocurrencies such as Bitcoin, Ethereum, and Litecoin. Therefore, purchasers will need to hold existing cryptocurrency in any third-party wallet such as Coinbase or Binance. Purchasers will then deposit cryptocurrency from their third party wallet into their AABB Wallet to exchange...

Continue reading

First Series of Third-Party Brands Ship From Tinley’s Long Beach Facility & Good Stuff Beverage Co. Enters Into Manufacturing Agreement

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. PERSONS. LOS ANGELES and TORONTO, March 22, 2021 (GLOBE NEWSWIRE) — The Tinley Beverage Company Inc. (CSE:TNY, OTC:TNYBF) (“Tinley’s” or “Company”) is pleased to announce that the first series of third-party products have been manufactured and shipped from the Company’s facility in Long Beach, California. The Company is also delighted to announce that Good Stuff Beverage Co. (“GSBC”), a pioneering California cannabis and CBD beverage brand, will move production of its assortment of natural tonics to Tinley’s facility. Good Stuff Beverages Moves Production to Tinley’s Facility GSBC’s classic flavours contain an innovative, terpene-infused formula. The highly anticipated, refreshed lineup showcases the brand’s introduction of strain-specific, high-dose...

Continue reading

Quhuo Announces Change to Board of Directors

BEIJING, March 22, 2021 (GLOBE NEWSWIRE) — Quhuo Limited (NASDAQ: QH) (“Quhuo” or the “Company”), a leading tech-enabled workforce operational solution platform in China, announced today that Mr. Yung-Hung Chang has resigned from his position as a member of the board of directors for personal reasons, effective on March 22, 2021. The resignation of Mr. Chang did not result from any disagreement with the Company on any matter relating to the Company’s business operations, financial reporting or controls, policies or practices. Leslie Yu, Chairman and Chief Executive Officer of QUHUO, commented, “On behalf of the Board, I would like to express my sincere gratitude to Mr. Chang for his valuable contributions to Quhuo during his tenure on the Board. We wish him continued success in his future endeavors.” About Quhuo Limited Quhuo Limited...

Continue reading

Goliath Resources Limited Common Shares Now DTC Eligible

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. TORONTO, March 22, 2021 (GLOBE NEWSWIRE) — Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (Frankfurt: B4IF) (the “Company” or “Goliath”) is pleased to announce that its common shares are now eligible for settlement through the Depository Trust Company (“DTC”), a subsidiary of the Depository Trust & Clearing Corp. that manages the electronic clearing and settlement of publicly traded companies in the United States. Goliath‘s common shares are now fully DTC eligible and are tradeable in the United States under the ticker symbol “GOTRF” on the OTCQB Venture Market. Through an electronic method of clearing securities, DTC eligibility reduces costs and accelerates the...

Continue reading

Doré Copper Consolidates and Options the High-Grade Norbeau Gold Properties in the Chibougamau Mining Camp, Quebec     

TORONTO, March 22, 2021 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (the “Corporation” or “Doré Copper“) (TSXV: DCMC; OTCQB: DRCMF; FRA: DCM) is pleased to announce that it has entered into option agreements (the “Option Agreements”) to acquire a 100% interest in the former producing Norbeau gold mine property and the contiguous Beaurox property, a major land position totaling approximately 1,400 hectares (the “Properties”), located 15 kilometers by road north from the Corporation’s Copper Rand mill in the Chibougamau mining camp in northwestern Québec, Canada (Figure 1). All dollar amounts are stated in Canadian Dollars. HighlightsCash payments totaling $465,000 over three years ($135,000 over the first year) Issuance of common shares in the Corporation (“Shares”) totaling $675,000 equivalent...

Continue reading

Doré Copper consolide et conclut des ententes d’option sur les propriétés à haute teneur en or de Norbeau dans le camp minier de Chibougamau, au Québec   

TORONTO, 22 mars 2021 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (la « Société » ou « Doré Copper ») (TSXV : DCMC; OTCQB : DRCMF; FRA : DCM) est heureuse d’annoncer qu’elle a conclu des ententes d’option (les « ententes d’option ») en vue d’acquérir une participation de 100 % dans la propriété hôte de l’ancienne mine Norbeau (or) et dans la propriété adjacente Beaurox, une importante position de terrain totalisant approximativement 1 400 hectares (les « propriétés »), à 15 kilomètres (par route) de l’usine Copper Rand de la Société, dans le camp minier de Chibougamau, dans le nord-ouest du Québec (Canada) (figure 1). Tous les montants sont exprimés en dollars canadiens. Faits saillantsPaiement en espèces totalisant 465 000 $ sur trois ans (135 000 $ au cours de la première année). Émission d’un nombre d’actions ordinaires de...

Continue reading

Trailbreaker Resources Announces Staking of the Swan Property, Formation of the Atsutla Gold Project, and Plans for 2021 Exploration

VANCOUVER, British Columbia, March 22, 2021 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (Trailbreaker) is pleased to announce the recent staking of the Swan property in northwestern British Columbia (BC) and its inclusion in the newly formed Atsutla Gold Project. The Swan property covers a historically drilled molybdenum porphyry prospect that has never been assayed for gold. It is situated just 20 km northeast of the recent high-grade gold discoveries at Trailbreaker’s Willie Jack property. Together, the Willie Jack and Swan properties form the 100%-owned Atsutla Gold Project, covering over 14,000 hectares of ground. The project, named after the Atsutla mountain range, is located 70 km south of the Yukon-BC border and 130 km northwest of Dease Lake, BC. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7206ae1c-b1fb-4049-b575-6ead0f5aafed Willie...

Continue reading

Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH

-TERN-501 is designed to have high metabolic stability, enhanced liver distribution and high selectivity for THR-β- -Top-line data expected in the second half of 2021- FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, today announced the initiation of dosing in a Phase 1 clinical trial evaluating TERN-501, a selective thyroid hormone receptor beta (THR-β) agonist with high metabolic stability, enhanced liver distribution and greater selectivity for THR-β when compared with other THR-β agonists in development. Terns expects to report initial...

Continue reading

Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer

NEW YORK and CLEVELAND, March 22, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Michael Amoroso, Executive Vice President, Chief Operating Officer (COO) and principal executive officer at Abeona, has been promoted to President, Chief Executive Officer (CEO) and a member of the company’s Board of Directors, effective immediately. “Michael’s promotion to CEO reflects his unwavering commitment and outstanding operational leadership during a period of important transition for the company, and the Board fully supports him and the Abeona senior management team,” said Steven H. Rouhandeh, Chairman of Abeona’s Board of Directors. “Under Michael’s stewardship, Abeona has remained focused on the strategy of providing our novel gene and cell therapies...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.